"We have reviewed our biorepository and identified a set of pineoblastoma samples. Those samples are being processed and our goal is to perform whole genome/exome sequencing by the end of July. This will allow us to find specific genetic mutations within each patient’s tumor and identify commonalities that we may be able to target with specific drugs."- Dr. Lu and Dr. Pillay Smiley
